Next Article in Journal
Development and Applications of the Copper-Catalyzed Azide-Alkyne Cycloaddition (CuAAC) as a Bioorthogonal Reaction
Previous Article in Journal
Correction: Chae, H.S., et al. Anti-Inflammatory Effects of 6,8-Diprenyl-7,4′-dihydroxyflavanone from Sophora tonkinensis on Lipopolysaccharide-Stimulated RAW 264.7 Cells. Molecules. 2016, 21, 1049.
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Chae, H.S.; et al. Atractylodin Inhibits Interleukin-6 by Blocking NPM-ALK Activation and MAPKs in HMC-1. Molecules 2016, 21, 1169

College of Pharmacy, Dongguk University-Seoul, 32 Dongguk-lo, Ilsandong-gu, Goyang-si, Gyeonggi-do 410-820, Korea
*
Author to whom correspondence should be addressed.
Molecules 2016, 21(10), 1412; https://doi.org/10.3390/molecules21101412
Submission received: 12 October 2016 / Accepted: 19 October 2016 / Published: 25 October 2016
(This article belongs to the Section Natural Products Chemistry)
The authors wish to make the following correction to their paper [1]. In Panel D of Figure 2, the data was incorrectly displayed. The correct version of Figure 2D is as follows:
The change does not affect the scientific results. The manuscript will be updated and the original will remain online on the article webpage. The authors would like to apologize for any inconvenience caused to readers by these changes.

Reference

  1. Chae, H.S.; Kim, Y.M.; Chin, Y.W. Atractylodin Inhibits Interleukin-6 by Blocking NPM-ALK Activation and MAPKs in HMC-1. Molecules 2016, 21, 1169. [Google Scholar] [CrossRef] [PubMed]
Figure 2. (D) HMC-1 was treated with the indicated concentrations of Atractylodin for 0.5 h prior to being incubated with PMA (50 nM) plus A23187 (1 μM) for 0.5 h and phospho and total NPM-ALK, AKT, PLCγ1, JAK2, and STAT3 were detected by immunoblot analysis as described in Materials and Methods.
Figure 2. (D) HMC-1 was treated with the indicated concentrations of Atractylodin for 0.5 h prior to being incubated with PMA (50 nM) plus A23187 (1 μM) for 0.5 h and phospho and total NPM-ALK, AKT, PLCγ1, JAK2, and STAT3 were detected by immunoblot analysis as described in Materials and Methods.
Molecules 21 01412 g001

Share and Cite

MDPI and ACS Style

Chae, H.-S.; Kim, Y.-M.; Chin, Y.-W. Correction: Chae, H.S.; et al. Atractylodin Inhibits Interleukin-6 by Blocking NPM-ALK Activation and MAPKs in HMC-1. Molecules 2016, 21, 1169. Molecules 2016, 21, 1412. https://doi.org/10.3390/molecules21101412

AMA Style

Chae H-S, Kim Y-M, Chin Y-W. Correction: Chae, H.S.; et al. Atractylodin Inhibits Interleukin-6 by Blocking NPM-ALK Activation and MAPKs in HMC-1. Molecules 2016, 21, 1169. Molecules. 2016; 21(10):1412. https://doi.org/10.3390/molecules21101412

Chicago/Turabian Style

Chae, Hee-Sung, Young-Mi Kim, and Young-Won Chin. 2016. "Correction: Chae, H.S.; et al. Atractylodin Inhibits Interleukin-6 by Blocking NPM-ALK Activation and MAPKs in HMC-1. Molecules 2016, 21, 1169" Molecules 21, no. 10: 1412. https://doi.org/10.3390/molecules21101412

APA Style

Chae, H. -S., Kim, Y. -M., & Chin, Y. -W. (2016). Correction: Chae, H.S.; et al. Atractylodin Inhibits Interleukin-6 by Blocking NPM-ALK Activation and MAPKs in HMC-1. Molecules 2016, 21, 1169. Molecules, 21(10), 1412. https://doi.org/10.3390/molecules21101412

Article Metrics

Back to TopTop